drugset / Trial / NCT07315555
Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma
RandomizedCrossoverOpen-labelTreatment
Summary
Complementary and adjunctive therapies are increasingly being explored to enhance asthma control and reduce airway inflammation. Nigella sativa (black seed) is a medicinal plant used traditionally in multiple regions and has demonstrated anti-inflammatory, immunomodulatory, and bronchodilator effects. Its potential as an adjuvant therapy in asthma has attracted attention in both preclinical and clinical research
Timeline
- Start
- 2026-01-01
- Primary completion
- 2026-06-01
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nigella Sativa Oil | Traditional medicine (herbal / TCM) | 50 mg/kg | Oral |
| Subject | Nigella Sativa Oil | Traditional medicine (herbal / TCM) | 100 mg/kg | Oral |
| Background | Fluticasone propionate | Other / unclassified | 200 ug | Inhaled |
Indications
No indication recorded.